BHR Pharma achieves recruitment milestone in SyNAPSe Phase 3 trial
The company expects to recruit around 1,200 patients with severe TBI (Glasgow Coma Scale scores of 4-8), who have sustained a closed-head trauma in SyNAPSe trial. The results

The company expects to recruit around 1,200 patients with severe TBI (Glasgow Coma Scale scores of 4-8), who have sustained a closed-head trauma in SyNAPSe trial. The results

Thionyl chloride is an intermediate used by industrial customers to manufacture agrochemicals, dyestuffs, fine chemicals and pharmaceuticals. The company expects to complete the expansion in the second half

The new JV – Aurospharma – intends to construct a plant to manufacture non penicillin and non cephalosporin Rx generics and other drugs that are categorized as over

The grant of $600,000 is expected to support the research to characterize the role of the phosphoinositide 3-kinase (PI3K) in preclinical models of skin autoimmune inflammation. Dynavax vice

Stagliano, recently served as the CEO and co-founder of CytomX Therapeutics, will succeed interim CEO Peter Van Vlasselear. Earlier, she worked as the COO of CytomX, which launched

As part of its expansion program, Xcelience has currently included a MG Futura (capsule-filling machine for powder and pellets), LCI Multi-granulator MG-55 (extruder), QJ-230T marumerizer (spheronizer), and wurster

The results from a placebo-controlled, randomized, six-week Phase II study demonstrated improvement on the Conners’ Adult ADHD Rating Scale-Investigator Rated Total ADHD Symptoms Score (CAARS-INV) compared to placebo.

Teva’s Levetiracetam tablets are the generic version of UCB Pharma’s Keppra (levetiracetam). The drug is available in 250, 500, 750 and 1,000mg film-coated tablets in the market. Levetiracetam

The MPR Mobile drug database with Drug Interactions Checker comprises around 7,000 agents with over 3,800 detailed drug-drug, drug-alcohol, drug-food and drug-herbal interactions. MPR Mobile has alo enhanced

The collaboration is formed for scientists who manufacture nanoparticles and for those who work with biomolecule applications and liposome in the area of drug delivery. The companies are